BNP Paribas Financial Markets’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
|
|||||
|
2025
Q1 | $1.87M | Sell |
|
|||||
|
2024
Q4 | $3.91M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $727K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $17 | Sell |
|
|||||
|
2020
Q1 | $69 | Hold |
|
|||||
|
2019
Q4 | $74 | Sell |
|
|||||
|
2019
Q3 | $2.21K | Hold |
|
|||||
|
2019
Q2 | $6.19K | Sell |
|
|||||
|
2019
Q1 | $15.4K | Buy |
|
|||||
|
2018
Q4 | $1.36K | Sell |
|
|||||
|
2018
Q3 | $7.59K | Buy |
|
|||||
|
2018
Q2 | $6.43K | Sell |
|
|||||
|
2018
Q1 | $33.1K | Buy |
|
|||||
|
2017
Q4 | $30.6K | Buy |
|
|||||
|
2017
Q3 | $11.3K | Sell |
|
|||||
|
2017
Q2 | $17.1K | Buy |
|